Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 5749857, 18 pages
http://dx.doi.org/10.1155/2016/5749857
Review Article

Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy

Department of Nephrology, Second Hospital of Jilin University, Changchun 130041, China

Received 28 May 2015; Accepted 22 July 2015

Academic Editor: David W. Powell

Copyright © 2016 Guang-dong Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Scully, “Diabetes in numbers,” Nature, vol. 485, no. 7398, pp. 52–53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Vivian and C. Mannebach, “Therapeutic approaches to slowing the progression of diabetic nephropathy—is less best?” Drugs in Context, vol. 2013, Article ID 212249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R. J. Macisaac, E. I. Ekinci, and G. Jerums, “Markers of and risk factors for the development and progression of diabetic kidney disease,” American Journal of Kidney Diseases, vol. 63, no. 2, pp. S39–S62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Skupien, J. H. Warram, A. M. Smiles et al., “The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease,” Kidney International, vol. 82, no. 5, pp. 589–597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. S. Kanwar, L. Sun, P. Xie, F.-Y. Liu, and S. Chen, “A glimpse of various pathogenetic mechanisms of diabetic nephropathy,” Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 395–423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Reddy, J. Tak Park, and R. Natarajan, “Epigenetic modifications in the pathogenesis of diabetic nephropathy,” Seminars in Nephrology, vol. 33, no. 4, pp. 341–353, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. O. Kolset, F. P. Reinholt, and T. Jenssen, “Diabetic nephropathy and extracellular matrix,” The Journal of Histochemistry and Cytochemistry, vol. 60, no. 12, pp. 976–986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. D. Sun, W. P. Cui, Q. Y. Guo, and L. N. Miao, “Histone lysine methylation in diabetic nephropathy,” Journal of Diabetes Research, vol. 2014, Article ID 654148, 9 pages, 2014. View at Publisher · View at Google Scholar
  9. A. P. Sanchez and K. Sharma, “Transcription factors in the pathogenesis of diabetic nephropathy,” Expert Reviews in Molecular Medicine, vol. 11, article e13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. A. K. H. Lim, “Diabetic nephropathy—complications and treatment,” International Journal of Nephrology and Renovascular Disease, vol. 7, pp. 361–381, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. L. Heerspink and D. de Zeeuw, “The kidney in type 2 diabetes therapy,” Review of Diabetic Studies, vol. 8, no. 3, pp. 392–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Yamout, I. Lazich, and G. L. Bakris, “Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease,” Advances in Chronic Kidney Disease, vol. 21, no. 3, pp. 281–286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. F. Fried, N. Emanuele, J. H. Zhang et al., “Combined angiotensin inhibition for the treatment of diabetic nephropathy,” The New England Journal of Medicine, vol. 369, no. 20, pp. 1892–1903, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. X.-L. Tong, L. Dong, L. Chen, and Z. Zhen, “Treatment of diabetes using traditional Chinese medicine: past, present and future,” The American Journal of Chinese Medicine, vol. 40, no. 5, pp. 877–886, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Shi, X. G. Lu, L. B. Zhan et al., “The effects of the Chinese medicine ZiBu PiYin recipe on the hippocampus in a rat model of diabetes-associated cognitive decline: a proteomic analysis,” Diabetologia, vol. 54, no. 7, pp. 1888–1899, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. H.-L. Zhao, Y. Sui, C.-F. Qiao et al., “Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression,” Diabetes, vol. 61, no. 4, pp. 933–943, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Wen, Y. Zeng, L. Liu et al., “Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 144–150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Teschke, A. Wolff, C. Frenzel, A. Eickhoff, and J. Schulze, “Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders,” World Journal of Gastroenterology, vol. 21, no. 15, pp. 4466–4490, 2015. View at Google Scholar
  19. G. Wang, B. Mao, Z.-Y. Xiong et al., “The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China,” Clinical Therapeutics, vol. 29, no. 7, pp. 1456–1467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. T. Zhao, H. J. Zhang, X. G. Lu et al., “Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling,” PLoS ONE, vol. 9, no. 3, Article ID e90807, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Liu, L.-Q. Tang, L.-M. Chen, X.-Q. Chen, S.-T. Zhang, and Y. Wei, “Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-β1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy,” Zhongguo zhongyao zazhi, vol. 33, no. 1, pp. 68–72, 2008. View at Google Scholar · View at Scopus
  22. W.-J. Geng, R.-B. Wei, and W. Mao, “Protective effects of compound shenhua tablet on diabetic nephropathy rats,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 32, no. 3, pp. 352–355, 2012. View at Google Scholar · View at Scopus
  23. Y. W. Zhang, D. Xie, B. Xia, R. T. Zhen, I.-M. Liu, and J.-T. Cheng, “Suppression of transforming growth factor-β1 gene expression by danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats,” Hormone and Metabolic Research, vol. 38, no. 2, pp. 82–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. H.-L. Ke, Y.-W. Zhang, B.-F. Zhou, and R.-T. Zhen, “Effects of Danggui Buxue Tang, a traditional Chinese herbal decoction, on high glucose-induced proliferation and expression of extracellular matrix proteins in glomerular mesangial cells,” Natural Product Research, vol. 26, no. 11, pp. 1022–1026, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. I.-M. Liu, T.-F. Tzeng, S.-S. Liou, and C. J. Chang, “Beneficial effect of traditional chinese medicinal formula Danggui-Shaoyao-San on advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 140103, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Fang, X. Wan, W. Deng et al., “Fufang Xue Shuan tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats,” Experimental and Therapeutic Medicine, vol. 4, no. 5, pp. 871–876, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Yokozawa, N. Yamabe, E. J. Cho, T. Nakagawa, and S. Oowada, “A study on the effects to diabetic nephropathy of hachimi-jio-gan in rats,” Nephron Experimental Nephrology, vol. 97, no. 2, pp. e38–e48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Kiga, T. Nakagawa, K. Koizumi et al., “Expression patterns of plasma proteins in spontaneously diabetic rats after oral administration of a Kampo medicine, Hachimi-jio-gan, using SELDI ProteinChip platform,” Biological & Pharmaceutical Bulletin, vol. 28, no. 6, pp. 1031–1037, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Nakagawa, T. Yokozawa, N. Yamabe et al., “Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats,” Journal of Pharmacy and Pharmacology, vol. 57, no. 9, pp. 1205–1212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Yamabe and T. Yokozawa, “Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus,,” The Journal of Pharmacy and Pharmacology, vol. 58, no. 4, pp. 535–545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Zhou, H. Dong, Y. Huang et al., “Hu-Lu-Ba-Wan attenuates diabetic nephropathy in type 2 diabetic rats through PKC-α/NADPH oxidase signaling pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 504642, 10 pages, 2013. View at Publisher · View at Google Scholar
  32. X.-Y. Song, Q. Chen, and X.-Y. Qi, “Effect of liuwei dihuang pill on erythrocyte aldose reductase activity in early diabetic nephropathy patients,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 24, no. 12, pp. 1087–1090, 2004. View at Google Scholar · View at Scopus
  33. P.-C. Hsu, Y.-T. Tsai, J.-N. Lai, C.-T. Wu, S.-K. Lin, and C.-Y. Huang, “Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study,” Journal of Ethnopharmacology, vol. 156, pp. 358–364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. I.-M. Liu, T.-F. Tzeng, S.-S. Liou, and C. J. Chang, “The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription,” Journal of Ethnopharmacology, vol. 124, no. 2, pp. 211–218, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. J. J. Yoon, Y. J. Lee, D. G. Kang, and H. S. Lee, “Protective role of oryeongsan against renal inflammation and glomerulosclerosis in db/db mice,” The American Journal of Chinese Medicine, vol. 42, no. 6, pp. 1431–1452, 2014. View at Publisher · View at Google Scholar
  36. Z. A. Guo, C. J. Yu, G. Liu, F. C. Meng, Y. Li, and S. L. Peng, “Treatment of stage 3b diabetic kidney disease patients with macroalbuminuria by Qizhi Jiangtang capsule: a multicenter randomized control clinical study,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 34, no. 9, pp. 1047–1052, 2014. View at Google Scholar · View at Scopus
  37. M.-Z. Li, Y.-B. Gao, and M.-F. Ma, “Effects of qiwei granule on the protein and mRNA expressions of renal tissue transforming growth factor-beta1 in KK-Ay mice with spontaneous type 2 diabetes mellitus,” Zhongguo Zhongxiyi jiehe zazhi, vol. 32, no. 12, pp. 1675–1678, 2012. View at Google Scholar · View at Scopus
  38. G.-B. Chen, L.-B. Wei, W. Xiao, and H.-B. Long, “Effect of Shenkangwan on mesangial cell NO and TGF-beta1 excretion in rats with early diabetic nephropathy,” Journal of Southern Medical University, vol. 26, no. 4, pp. 526–528, 2006. View at Google Scholar · View at Scopus
  39. H.-B. Long, H.-X. Niu, X.-Y. Li et al., “Effects of Shenkangwan on renal expressions of angiotensin II and its type I receptor in rats with early diabetic nephropathy,” Journal of Southern Medical University, vol. 30, no. 4, pp. 805–809, 2010. View at Google Scholar · View at Scopus
  40. J.-J. Yin, Y. Yang, Q.-B. Wang, Y. Li, and D.-K. Yin, “Effect of Chinese herbal medicine with Supplement Qi and Activating Blood Circulation on tubular reabsorption function of diabetic nephropathy rats,” Journal of Chinese medicinal materials, vol. 36, no. 6, pp. 953–958, 2013. View at Google Scholar · View at Scopus
  41. D.-K. Yin, Y. Yang, and Y. Li, “Effect of supplementing Qi and activating blood circulation method on protein uptake in NRK-52E cells injured by high glucose,” Journal of Chinese Medicinal Materials, vol. 37, no. 1, pp. 91–94, 2014. View at Google Scholar · View at Scopus
  42. M. Huang, C. Zhu, Q.-L. Liang et al., “Effect of Tangshen formula on phospholipids metabolism in diabetic nephropathy patients,” Acta Pharmaceutica Sinica, vol. 46, no. 7, pp. 780–786, 2011. View at Google Scholar · View at Scopus
  43. Z.-T. Jiang, Q.-L. Liang, and Y.-M. Wang, “Effects of tangshen recipe on the homocysteine metabolism of patients with diabetic nephropathy,” Zhongguo Zhongxiyi jiehe zazhi, vol. 31, no. 8, pp. 1057–1061, 2011. View at Google Scholar · View at Scopus
  44. J. Hu, X. Fan, X. Meng, Y. Wang, Q. Liang, and G. Luo, “Evidence for the involvement of JAK/STAT/SOCS pathway in the mechanism of Tangshen formula-treated diabetic nephropathy,” Planta Medica, vol. 80, no. 8-9, pp. 614–621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. Y.-L. Wu, C. Wei, and H.-T. Wang, “Effect of tongshenluo capsule on the components of extracellular matrix and their metabolism in kidney of rats with diabetic nephropathy,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 27, no. 4, pp. 326–330, 2007. View at Google Scholar · View at Scopus
  46. Y. Zhao and X.-L. Zhang, “Effect of tongxinluo capsule on plasma endothelin in patients with diabetic nephropathy,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 25, no. 2, pp. 131–133, 2005. View at Google Scholar · View at Scopus
  47. J.-Y. Wang, Y.-B. Gao, N. Zhang et al., “Tongxinluo ameliorates renal structure and function by regulating mir-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy,” The American Journal of Physiology—Renal Physiology, vol. 306, no. 5, pp. F486–F495, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. C.-C. Lin, L.-T. Lin, M.-H. Yen, J.-T. Cheng, C.-H. Hsing, and C.-H. Yeh, “Renal protective effect of Xiao-Chai-Hu-Tang on diabetic nephropathy of type 1-diabetic mice,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 984024, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. X.-M. Ji, Q. Wang, and F. Qi, “Effect of xiaoke granule on blood glucose, urinary protein and glomerular morphology in rats with diabetic nephropathy,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 24, no. 6, pp. 534–537, 2004. View at Google Scholar · View at Scopus
  50. X.-M. Ji, Q. Wang, M.-X. Gong, Y.-Q. Du, and D.-X. Jia, “Effects of Xiaoke granule on transforming growth factor-beta1, expression and proliferation in rat mesangial cells,” Chinese Medical Journal, vol. 119, no. 21, pp. 1839–1842, 2006. View at Google Scholar · View at Scopus
  51. J.-S. Wu, R. Shi, J. Zhong et al., “Renal protective role of Xiexin decoction with multiple active ingredients involves inhibition of inflammation through downregulation of the nuclear factor-κB pathway in diabetic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 715671, 15 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. J. S. Wu, R. Shi, X. Lu, Y. M. Ma, and N. N. Cheng, “Combination of active components of xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/smad pathways in db/db diabetic mice,” PLoS ONE, vol. 10, no. 3, Article ID e0122661, 2015. View at Publisher · View at Google Scholar
  53. D.-Y. Tang, S.-S. Guo, and R.-Y. Sun, “Effect of xianzhen tablet on content of advanced glycosylation end products (AGEs) and mRNA expression of AGE-specific cellular receptor in renal cortex of diabetic rats,” Zhongguo Zhongxiyi jiehe zazhi, vol. 25, no. 1, pp. 60–63, 2005. View at Google Scholar · View at Scopus
  54. L. Zhao, H. Gao, Y. Zhao, and D. Lin, “Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathy,” Journal of Ethnopharmacology, vol. 142, no. 3, pp. 647–656, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. J. W. Ju, S. H. Mu, Y. Z. Yin, C. K. Lu, X. Y. Sun, and L. X. Deng, “Effects of zao huang mixture (see text) on the expressions of TGF-beta1 and Col IV in human glomerular mesangial cells cultured in high glucose environment,” Journal of Traditional Chinese Medicine, vol. 31, no. 2, pp. 127–129, 2011. View at Google Scholar
  56. J. Ma, L. Xu, J. Dong et al., “Effects of zishentongluo in patients with early-stage diabetic nephropathy,” The American Journal of Chinese Medicine, vol. 41, no. 2, pp. 333–340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. H. He, X. Yang, X. Zeng et al., “Protective effect of Liuwei Dihuang decoction on early diabetic nephropathy induced by streptozotocin via modulating ET-ROS axis and matrix metalloproteinase activity in rats,” The Journal of Pharmacy and Pharmacology, vol. 59, no. 9, pp. 1297–1305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. H.-R. Liu, X.-Y. Tang, D.-Z. Dai, and Y. Dai, “Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats,” Journal of Ethnopharmacology, vol. 118, no. 3, pp. 466–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. W. Xiao, L.-B. Wei, Y. Ma, H.-B. Long, and G.-B. Chen, “Renal protective effect of Shenkang pill on diabetic rats,” Zhongguo zhongyao zazhi, vol. 31, no. 12, pp. 1006–1009, 2006. View at Google Scholar · View at Scopus
  60. W. Xiao, Y. Ma, and L.-B. Wei, “Effect of shenkangwan on TGF-beta1 and FN in rat mesangial cells cultured by high glucose,” Journal of Chinese Medicinal Materials, vol. 29, no. 9, pp. 924–927, 2006. View at Google Scholar · View at Scopus
  61. H.-B. Long, H. Zhang, J. Zhong, Y. Zhu, J.-H. He, and L.-B. Wei, “Protective effects of Shenkangwan against podocyte injury in rats with early diabetic nephropathy,” Journal of Southern Medical University, vol. 28, no. 7, pp. 1268–1272, 2008. View at Google Scholar · View at Scopus
  62. N. Zhang, Y. Gao, D. Zou et al., “Effects of Chinese medicine Tong xinluo on diabetic nephropathy via inhibiting TGF-β1-induced epithelial-to-mesenchymal transition,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 123497, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Li, W. Wang, J. Xue, Y. Gu, and S. Lin, “Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 412–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Nie, S. Li, Y. Yi et al., “Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice,” BMC Complementary and Alternative Medicine, vol. 14, article 148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Mou, Z.-H. Ni, and Q.-Y. Zhang, “Expression of c-met in human kidney fibroblasts induced by high glucose in vitro and the regulation of Radix Astragali,” Journal of Chinese Integrative Medicine, vol. 6, no. 5, pp. 482–487, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. F. L. Wang, L. Q. Tang, F. Yang, L. N. Zhu, M. Cai, and W. Wei, “Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats,” Molecular Biology Reports, vol. 40, no. 3, pp. 2405–2418, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Lu, L. Tao, W. Mei et al., “Effect of curcumin on the expression of p-STAT3 and IκB in db/db mice,” Journal of Central South University (Medical Sciences), vol. 39, no. 6, pp. 591–597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. J.-P. Liu, L. Feng, M.-M. Zhu et al., “The in vitro protective effects of curcumin and demethoxycurcumin in Curcuma longa extract on advanced glycation end products-induced mesangial cell apoptosis and oxidative stress,” Planta Medica, vol. 78, no. 16, pp. 1757–1760, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. N. Zheng, X. Lin, Q. Wen et al., “Effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L. (Oxalidaceae) roots, on advanced glycation end-product-mediated renal injury in type 2 diabetic KKAy mice,” Toxicology Letters, vol. 219, no. 1, pp. 77–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. Xie, Q. Wang, J. Liu, J. Xie, K. Xue, and Q. Tang, “Dracorhodin perchlorate inhibit high glucose induce serum and glucocorticoid induced protein kinase 1 and fibronectin expression in human mesangial cells,” Zhongguo Zhongyao Zazhi, vol. 35, no. 15, pp. 1996–2000, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. H.-W. Zhu, Z.-F. Shi, and Y.-Y. Chen, “Effect of extract of ginkgo bilboa leaf on early diabetic nephropathy,” Zhongguo Zhongxiyi jiehe zazhi, vol. 25, no. 10, pp. 889–891, 2005. View at Google Scholar · View at Scopus
  72. X.-S. Li, X.-J. Fu, and X.-J. Lang, “Effect of extract of Gingko biloba on soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in patients with early diabetic nephropathy,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 27, no. 5, pp. 412–414, 2007. View at Google Scholar · View at Scopus
  73. J.-Y. Wang, X.-X. Yin, Y.-M. Wu et al., “Ginkgo biloba extract suppresses hypertrophy and extracellular matrix accumulation in rat mesangial cells,” Acta Pharmacologica Sinica, vol. 27, no. 9, pp. 1222–1230, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Fujita, H. Sasaki, A. Doi et al., “Ferulic acid prevents pathological and functional abnormalities of the kidney in Otsuka Long-Evans Tokushima Fatty diabetic rats,” Diabetes Research and Clinical Practice, vol. 79, no. 1, pp. 11–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Choi, B. H. Kim, J. Naowaboot et al., “Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes,” Experimental & Molecular Medicine, vol. 43, no. 12, pp. 676–683, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. L. Zhou, X.-F. An, S.-C. Teng et al., “Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy,” Journal of Medicinal Food, vol. 15, no. 5, pp. 461–468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  77. W. Qiu, Y. Zhou, L. Jiang et al., “Genipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice,” PLoS ONE, vol. 7, no. 7, Article ID e41391, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. F. Wang, F. Lu, and L. Xu, “Effects of Houttuynia cordata Thumb on expression of BMP-7 and TGF-β1 in the renal tissues of diabetic rats,” Journal of Traditional Chinese Medicine, vol. 27, no. 3, pp. 220–225, 2007. View at Google Scholar · View at Scopus
  79. M.-Y. Qi, Kai-Chen, H.-R. Liu, Y.-H. Su, and S.-Q. Yu, “Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats,” Journal of Ethnopharmacology, vol. 138, no. 3, pp. 731–736, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. G. T. Lee, H. Ha, M. Jung et al., “Delayed treatment with lithospermate B attenuates experimental diabetic renal injury,” Journal of the American Society of Nephrology, vol. 14, no. 3, pp. 709–720, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Y. Hur, S. H. Kim, M.-A. Choi et al., “Protective effects of magnesium lithospermate B against diabetic atherosclerosis via Nrf2-ARE-NQO1 transcriptional pathway,” Atherosclerosis, vol. 211, no. 1, pp. 69–76, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. R. Zhao, Q.-W. Li, J. Li, and T. Zhang, “Protective effect of Lycium barbarum polysaccharide 4 on kidneys in streptozotocin-induced diabetic rats,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 9, pp. 711–719, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. Q. Wen, T. Liang, F. Qin et al., “Lyoniresinol 3α-O-β-D-glucopyranoside-mediated hypoglycaemia and its influence on apoptosis-regulatory protein expression in the injured kidneys of streptozotocin-induced mice,” PLoS ONE, vol. 8, no. 12, Article ID e81772, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. B. Wang, Q. Ni, X. Wang, and L. Lin, “Meta-analysis of the clinical effect of ligustrazine on diabetic nephropathy,” The American Journal of Chinese Medicine, vol. 40, no. 1, pp. 25–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Zhang, L. Feng, J. Gu et al., “The attenuation of Moutan cortex on oxidative stress for renal injury in AGEs-induced mesangial cell dysfunction and streptozotocin-induced diabetic nephropathy rats,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 463815, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  86. M.-H. Zhang, L. Feng, J.-F. Gu, J. Jiang, and X.-B. Jia, “Effect of Moutan Cortex on AGEs-induced mesangial cell proliferation and basement membrane thickening,” Zhongguo zhongyao zazhi, vol. 39, no. 3, pp. 478–482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. M.-H. Zhang, L. Feng, M.-M. Zhu et al., “The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 591–600, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. T. Yokozawa, N. Yamabe, H. Y. Kim et al., “Protective effects of morroniside isolated from corni fructus against renal damage in streptozotocin-induced diabetic rats,” Biological & Pharmaceutical Bulletin, vol. 31, no. 7, pp. 1422–1428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. Q.-N. Tu, H. Dong, and F.-E. Lu, “Effects of panax notoginoside on the nephropathy in rats with type 1 diabetes mellitus,” Chinese Journal of Integrative Medicine, vol. 17, no. 8, pp. 612–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. Q. Tu, J. Qin, H. Dong, F. Lu, and W. Guan, “Effects of Panax notoginoside on the expression of TGF-beta1 and Smad-7 in renal tissues of diabetic rats,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 31, no. 2, pp. 190–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  91. Q.-X. Li, H.-J. Zhong, H.-R. Gong et al., “Effect of compound Puerarin on the collage IV in streptozotocin-induced diabetic nephropathy rats,” Chinese Journal of Preventive Medicine, vol. 42, no. 4, pp. 254–259, 2008. View at Google Scholar · View at Scopus
  92. Y. Zhong, X. Zhang, X. Cai, K. Wang, Y. Chen, and Y. Deng, “Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats,” PLoS ONE, vol. 9, no. 1, Article ID e85690, 2014. View at Publisher · View at Google Scholar · View at Scopus
  93. Y. Zhang, H. Wang, L. Yu, and J. Chen, “The Puerarin improves renal function in STZ-induced diabetic rats by attenuating eNOS expression,” Renal Failure, vol. 37, no. 4, pp. 699–703, 2015. View at Publisher · View at Google Scholar
  94. Q. Gao, W.-S. Qin, Z.-H. Jia et al., “Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy,” Planta Medica, vol. 76, no. 1, pp. 27–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. D.-Q. Yu, Y. Gao, and X.-H. Liu, “Effects of Rhein on the hypertrophy of renal proximal tubular epithelial cells induced by high glucose and angiotensin II in rats,” Journal of Chinese Medicinal Materials, vol. 33, no. 4, pp. 570–574, 2010. View at Google Scholar · View at Scopus
  96. Z.-S. Wang, F. Gao, and F.-E. Lu, “Effect of ethanol extract of Rhodiola rosea on the early nephropathy in type 2 diabetic rats,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 33, no. 3, pp. 375–378, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. Y. Zhou, Q. Liao, Y. Luo, Z. Qing, Q. Zhang, and G. He, “Renal protective effect of Rosa laevigata Michx. by the inhibition of oxidative stress in streptozotocin-induced diabetic rats,” Molecular Medicine Reports, vol. 5, no. 6, pp. 1548–1554, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. X.-W. Li, Y. Liu, W. Hao, and J.-R. Yang, “Sequoyitol ameliorates diabetic nephropathy in diabetic rats induced with a high-fat diet and a low dose of streptozotocin,” Canadian Journal of Physiology and Pharmacology, vol. 92, no. 5, pp. 405–417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. H.-W. Chen, S.-L. Wang, and X.-Y. Chen, “Preliminary study on effects of sodium ferulate in treating diabetic nephropathy,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 26, no. 9, pp. 803–806, 2006. View at Google Scholar · View at Scopus
  100. S. Zhang, J. Yang, H. Li et al., “Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats,” European Journal of Pharmacology, vol. 692, no. 1–3, pp. 78–83, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. G. Liu, G.-J. Guan, T.-G. Qi et al., “Protective effects of Salvia miltiorrhiza on rats with streptozotocin diabetes and its mechanism,” Journal of Chinese Integrative Medicine, vol. 3, no. 6, pp. 459–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  102. S.-H. Lee, Y.-S. Kim, S.-J. Lee, and B.-C. Lee, “The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1409–1414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. D. Yin, J. Yin, Y. Yang, S. Chen, and X. Gao, “Renoprotection of Danshen Injection on streptozotocin-induced diabetic rats, associated with tubular function and structure,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 667–674, 2014. View at Publisher · View at Google Scholar · View at Scopus
  104. J. Su, P. Zhang, J.-J. Zhang, X.-M. Qi, Y.-G. Wu, and J.-J. Shen, “Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats,” Phytomedicine, vol. 17, no. 3-4, pp. 254–260, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. B. C. Chang, W. D. Chen, Y. Zhang, P. Yang, L. Liu, and J. Wang, “Effect of total glucosides of paeony on Wnt/beta-catenin signal transduction pathway expression in kidney of diabetic rats,” Zhongguo Zhongyao Zazhi, vol. 39, no. 19, pp. 3829–3835, 2014. View at Google Scholar
  106. Q.-H. Yang, Y. Liang, Q. Xu, Y. Zhang, L. Xiao, and L.-Y. Si, “Protective effect of tetramethylpyrazine isolated from Ligusticum chuanxiong on nephropathy in rats with streptozotocin-induced diabetes,” Phytomedicine, vol. 18, no. 13, pp. 1148–1152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. Q. Gao, W. Shen, W. Qin et al., “Treatment of db/db diabetic mice with triptolide: a novel therapy for diabetic nephropathy,” Nephrology Dialysis Transplantation, vol. 25, no. 11, pp. 3539–3547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. R.-X. Ma, N. Zhao, and W. Zhang, “The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients,” Zhonghua Nei Ke Za Zhi, vol. 52, no. 6, pp. 469–473, 2013. View at Google Scholar · View at Scopus
  109. X.-P. Sun, N.-S. Wang, Q. Xue, and F. Wang, “Volatile oil of Magnolia biondii inhibits expressions of P-selectin protein in serum and renal tissue of rats with diabetic nephropathy,” Journal of Chinese Integrative Medicine, vol. 6, no. 5, pp. 524–529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  110. H.-W. Gu, Z.-H. Ni, L.-Y. Gu et al., “Effects of Astragalus on expression of renal angiopoietin receptor Tie-2 in diabetic rats,” Journal of Chinese Integrative Medicine, vol. 5, no. 5, pp. 536–540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. D. Tang, B. He, Z.-G. Zheng et al., “Inhibitory effects of two major isoflavonoids in Radix Astragali on high glucose-induced mesangial cells proliferation and AGEs-induced endothelial cells apoptosis,” Planta Medica, vol. 77, no. 7, pp. 729–732, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. K. Agyemang, L. Han, E. Liu, Y. Zhang, T. Wang, and X. Gao, “Recent advances in Astragalus membranaceus anti-diabetic research: pharmacological effects of its phytochemical constituents,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 654643, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  113. Q. Wang, X. Shao, W. Xu et al., “Astragalosides IV inhibits high glucose-induced cell apoptosis through HGF activation in cultured human tubular epithelial cells,” Renal Failure, vol. 36, no. 3, pp. 400–406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. W. Wu, H. Geng, Z. Liu, H. Li, and Z. Zhu, “Effect of curcumin on rats/mice with diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials,” Journal of Traditional Chinese Medicine, vol. 34, no. 4, pp. 419–429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  115. Q. Sun, G. Yang, M. Zhang, M. Zhang, S. Chen, and P. Chen, “Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: a meta-analysis,” Journal of Traditional Chinese Medicine, vol. 35, no. 1, pp. 15–20, 2015. View at Publisher · View at Google Scholar
  116. N. Yamabe, K. S. Kang, E. Goto, T. Tanaka, and T. Yokozawa, “Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats,” Biological & Pharmaceutical Bulletin, vol. 30, no. 3, pp. 520–526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  117. W. Ma, K.-J. Wang, C.-S. Cheng et al., “Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy,” Journal of Ethnopharmacology, vol. 153, no. 3, pp. 840–845, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. X. Ma, X. Xie, C. Zuo, and J. Fan, “Effects of ginsenoside Rg1 on streptozocin-induced diabetic nephropathy in rats,” Journal of Biomedical Engineering, vol. 27, no. 2, pp. 342–347, 2010. View at Google Scholar · View at Scopus
  119. N. Mao, Y. Cheng, X.-L. Shi et al., “Ginsenoside Rg1 protects mouse podocytes from aldosterone-induced injury in vitro,” Acta Pharmacologica Sinica, vol. 35, no. 4, pp. 513–522, 2014. View at Publisher · View at Google Scholar · View at Scopus
  120. T. Yokozawa, H. Y. Kim, and N. Yamabe, “Amelioration of diabetic nephropathy by dried Rehmanniae Radix (Di Huang) extract,” The American Journal of Chinese Medicine, vol. 32, no. 6, pp. 829–839, 2004. View at Publisher · View at Google Scholar · View at Scopus
  121. Z. Dong and C. X. Chen, “Effect of catalpol on diabetic nephropathy in rats,” Phytomedicine, vol. 20, no. 11, pp. 1023–1029, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. H. Yin, X. Yan, and K. H. Yang, “Systematic review on sodium ferulate for treatment of diabetic nephropathy,” Zhongguo Zhongxiyi Jiehe Zazhi, vol. 29, no. 11, pp. 970–974, 2009. View at Google Scholar · View at Scopus
  123. H. Zhang, W. Sun, Y. Wan et al., “Preventive effects of multi-glycoside of Tripterygium wilfordii on glomerular lesions in experimental diabetic nephropathy,” Zhongguo Zhongyao Zazhi, vol. 35, no. 11, pp. 1460–1465, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. J.-P. Li, X.-L. He, and Q. Li, “Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 26, no. 5, pp. 415–418, 2006. View at Google Scholar · View at Scopus
  125. X.-L. He, J.-P. Li, Y.-P. Chen, Z.-G. Zhang, W.-Q. Lin, and J.-H. Chen, “Effects of Tangshenling Mixture and benazepril on rats with diabetic nephropathy and its mechanism,” Journal of Chinese Integrative Medicine, vol. 4, no. 1, pp. 43–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. H.-X. Song, J. Gong, and W. Chen, “Effect of triptolide on urinary monocyte chemottractant protein-1 in patients with diabetic nephropathy,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 25, no. 5, pp. 416–418, 2005. View at Google Scholar · View at Scopus
  127. J. Song, Y. H. Li, and X. D. Yang, “Effect of combined therapy with bailing capsule and benazepril on urinary albumin excretion rate and C-reactive protein in patients with early diabetic nephropathy,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 29, no. 9, pp. 791–793, 2009. View at Google Scholar · View at Scopus
  128. D.-Z. Guo, Y.-H. Wang, and Z.-Q. Chen, “Effect of treatment in 39 patients with diabetic nephropathy by safflor yellow and benazepril in combination,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 28, no. 4, pp. 360–363, 2008. View at Google Scholar · View at Scopus
  129. L. Zhao, L.-G. Lan, X.-L. Min et al., “Integrated treatment of traditional Chinese medicine and western medicine for early- and intermediate-stage diabetic nephropathy,” Journal of Southern Medical University, vol. 27, no. 7, pp. 1052–1055, 2007. View at Google Scholar · View at Scopus